Francesca Ammoscato
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Neurofilament heavy chain in secondary progressive multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: January 23, 2025
Effects of cladribine on intrathecal and peripheral B and plasma cells.
Journal: Clinical and experimental immunology
Published: September 04, 2024
Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells.
Journal: Clinical immunology (Orlando, Fla.)
Published: August 08, 2024
CSF neurofilament light chain profiling and quantitation in neurological diseases.
Journal: Brain communications
Published: November 06, 2023
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study.
Journal: Multiple sclerosis and related disorders
Published: November 03, 2021
CSF neurofilament light chain testing as an aid to determine treatment strategies in MS.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 27, 2020
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells.
Journal: Journal of neurology
Published: February 07, 2018
Cladribine: mechanisms and mysteries in multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: October 07, 2017
Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.
Journal: Gastroenterology
Published: October 09, 2013
The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis.
Journal: Fibrogenesis & tissue repair
Published: May 11, 2013
Absence of a role for interleukin-13 in inflammatory bowel disease.
Journal: European journal of immunology
Published: March 13, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026